The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
AINU is set to accelerate its expansion footprint, enhance operational capabilities
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Subscribe To Our Newsletter & Stay Updated
